MORVEN EDWARDS to Vaccines, Conjugate
This is a "connection" page, showing publications MORVEN EDWARDS has written about Vaccines, Conjugate.
Connection Strength
0.843
-
Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007 Jan 02; 25(1):55-63.
Score: 0.251
-
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 01; 188(1):66-73.
Score: 0.202
-
Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine. 2013 Aug 28; 31 Suppl 4:D66-71.
Score: 0.097
-
Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012 Jun 13; 30(28):4123-6.
Score: 0.093
-
Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin. 2008 Nov-Dec; 4(6):444-8.
Score: 0.074
-
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis. 2004 Aug 01; 190(3):558-64.
Score: 0.054
-
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. Clin Infect Dis. 2019 05 30; 68(12):2079-2086.
Score: 0.038
-
Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine. 2009 Jul 16; 27(33):4452-6.
Score: 0.019
-
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12.
Score: 0.013